Dare Bioscience Analyst Ratings
Dare Bioscience Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 878.88% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 07/13/2023 | 878.88% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 06/06/2023 | 878.88% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 05/22/2023 | 878.88% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 05/12/2023 | 878.88% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 03/31/2023 | 878.88% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 12/13/2022 | 878.88% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 12/01/2022 | 739.04% | JonesTrading | → $6 | Initiates Coverage On | → Buy |
| 04/01/2022 | 739.04% | HC Wainwright & Co. | $5 → $6 | Maintains | Buy |
| 06/30/2021 | 1438.25% | Roth Capital | $9 → $11 | Maintains | Buy |
| 12/18/2020 | 599.2% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
| 04/28/2020 | 948.8% | Brookline Capital | → $7.5 | Initiates Coverage On | → Buy |
| 08/17/2018 | 319.52% | Maxim Group | → $3 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/11/2023 | 878.88% | HC Wainwright & Co. | → 7 美元 | 重申 | 購買 → 購買 |
| 07/13/2023 | 878.88% | HC Wainwright & Co. | → 7 美元 | 重申 | 購買 → 購買 |
| 06/06/2023 | 878.88% | HC Wainwright & Co. | → 7 美元 | 重申 | → 購買 |
| 05/22/2023 | 878.88% | HC Wainwright & Co. | → 7 美元 | 重申 | 購買 → 購買 |
| 05/12/2023 | 878.88% | HC Wainwright & Co. | → 7 美元 | 重申 | 購買 → 購買 |
| 03/31/2023 | 878.88% | HC Wainwright & Co. | → 7 美元 | 重申 | → 購買 |
| 12/13/2022 | 878.88% | HC Wainwright & Co. | 6 美元 → 7 美元 | 維護 | 購買 |
| 2022 年 1 月 12 日 | 739.04% | JonesTrading | → 6 美元 | 啓動覆蓋開啓 | → 購買 |
| 04/01/2022 | 739.04% | HC Wainwright & Co. | 5 美元 → 6 美元 | 維護 | 購買 |
| 2021 年 6 月 30 日 | 1438.25% | 羅斯資本 | 9 美元 → 11 美元 | 維護 | 購買 |
| 2020 年 12 月 18 日 | 599.2% | HC Wainwright & Co. | → 5 美元 | 啓動覆蓋開啓 | → 購買 |
| 04/28/2020 | 948.8% | 布魯克林資本 | → 7.5 美元 | 啓動覆蓋開啓 | → 購買 |
| 08/17/2018 | 319.52% | Maxim 集團 | → 3 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for Dare Bioscience (DARE)?
Dare Bioscience（DARE）的目標價格是多少？
The latest price target for Dare Bioscience (NASDAQ: DARE) was reported by HC Wainwright & Co. on August 11, 2023. The analyst firm set a price target for $7.00 expecting DARE to rise to within 12 months (a possible 878.88% upside). 8 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月11日公佈了Dare Bioscience（納斯達克股票代碼：DARE）的最新目標股價。這家分析公司將目標股價定爲7.00美元，預計DARE將在12個月內升至878.88％（可能上漲878.88％）。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Dare Bioscience (DARE)?
Dare Bioscience（DARE）的最新分析師評級是多少？
The latest analyst rating for Dare Bioscience (NASDAQ: DARE) was provided by HC Wainwright & Co., and Dare Bioscience reiterated their buy rating.
Dare Bioscience（納斯達克股票代碼：DARE）的最新分析師評級由HC Wainwright & Co. 提供，Dare Bioscience重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Dare Bioscience (DARE)?
Dare Bioscience（DARE）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dare Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dare Bioscience was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Dare Bioscience的高管和客戶交談以及聽取業績電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Dare Bioscience的最後一次評級是在2023年8月11日提交的，因此你應該預計下一個評級將在2024年8月11日左右公佈。
Is the Analyst Rating Dare Bioscience (DARE) correct?
分析師對 Dare Bioscience (DARE) 的評級正確嗎？
While ratings are subjective and will change, the latest Dare Bioscience (DARE) rating was a reiterated with a price target of $0.00 to $7.00. The current price Dare Bioscience (DARE) is trading at is $0.72, which is within the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的Dare Bioscience（DARE）評級得到了重申，目標股價爲0.00美元至7.00美元。Dare Bioscience（DARE）目前的交易價格爲0.72美元，在分析師的預測區間內。